News | Radiation Oncology | April 17, 2020

Beamscan MR Motorized 3-D Water Phantom Receives FDA Clearance

PTW announces first North American installation and FDA 510(k) clearance of Beamscan MR motorized 3-D water phantom

PTW announces first North American installation and FDA 510(k) clearance of Beamscan MR motorized 3-D water phantom

PTW Beamscan MR for Elekta Unity

April 17, 2020 — PTW has installed the first Beamscan MR motorized 3-D water phantom in North America at the Princess Margaret Cancer Centre in Toronto, Ontario, Canada. In addition, PTW announces that the Beamscan MR water phantom recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for sale within the United States. The Beamscan MR motorized 3-D water phantom provides a dedicated, fully equipped solution for beam data commissioning and annual QA of MR-LINACs.

The Princess Margaret Cancer Centre is part of the University Health Network, which is affiliated with the University of Toronto. It is one of the largest comprehensive cancer treatment facilities in the world and the largest radiation treatment facility in Canada. It houses two state-of-the-art MR-LINAC systems: an Elekta Unity system as well as an MR-on-rail system combined with a linear accelerator and a brachytherapy afterloader (MRgRT system).

“We invested in the Beamscan MR because it is an essential tool for the commissioning and maintenance of our Elekta Unity MR-LINAC,” said Daniel Létourneau Ph.D., head of physics in the Radiation Medicine Program at Princess Margaret Cancer Centre. Létourneau leads clinical operations as well as the academic and education activities of the Medical Physics Department at the Princess Margaret Cancer Centre.

“The Beamscan MR enables us to conduct in-depth radiation beam characterization and quality assurance of our Unity MR-LINAC,” Létourneau added. “Because it is designed for compatibility with the Elekta Unity, we can perform accurate beam profile and depth-dose curve measurements in the specific geometry of the MR-LINAC.”

The Beamscan MR water phantom is available for both the Elekta Unity and ViewRay MRIdian MR-LINACs. It is the first motorized 3-D water phantom suitable for clinical use in a 1.5 T MR environment. The Beamscan MR phantom comes ready to use on a single carriage and includes everything needed for operation. 

PTW is continuously developing innovative dosimetry solutions to deliver fast, precise measurements for complex radiation equipment and treatment plans. PTW delivers a full line of dosimetry solutions for acceptance testing, beam data commissioning, and machine- and patient-specific QA.

For more information: www.ptwdosimetry.com

Related Content

Important milestone demonstrates the unrivalled experience, technological innovation and global market leadership of IBA and its clinical partners
News | Proton Therapy | September 25, 2020
September 25, 2020 — IBA (Ion Beam Applications SA) announced that more than 100,000 patients have now been treated w
An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Canon Medical Systems.

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Canon Medical Systems.

News | Cardiac Imaging | September 25, 2020
September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary arter
New research from King's College London has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke.

Canon Medical Systems

News | Cardiac Imaging | September 22, 2020
September 22, 2020 — New research from King's College London has
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases